[ET Net News Agency, 31 July 2024] REMEGEN (09995) rose 10% to HK$14.58, breaking above
the 10-D SMA of HK$14.476.
It hits an intra-day high of HK$14.6, and an intra-day low of HK$13.18. The total shares
traded was 1.27 million, with a value of HK$17.76m. The active buy/sell ratio is 70:30,
with net buying turnover of HK$6.63m. MORGAN STANLEY HK SEC accounts for greatest net
responsive buying turnover of HK$146,177, with volume weighted average price of HK$13.99.
J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$2.4m,
with volume weighted average price of HK$13.93. The stock has risen a combined 10.1% over
the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 14.580 % Chg +9.95%
High 14.600 Low 13.180
Shares Tr 1.27m Turnover 17.76m
10-D SMA 14.476 %H.V 125.049
20-D SMA 15.714 VWAP 14.006
50-D SMA 21.847 RSI14 34.659
----------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 70:30, with net buying
turnover of HK$6.63m, rising a combined 10.1% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 14.58 +9.95
HUTCHMED (00013) 29.40 +2.80
GENSCRIPT BIO (01548) 12.34 +4.05
INNOVENT BIO (01801) 38.60 +4.89
WUXI XDC (02268) 16.60 +7.93
WUXI BIO (02269) 11.40 +8.57
HIGHTIDE-B (02511) 1.21 +22.22
TIGERMED (03347) 29.70 +7.41
BEIGENE (06160) 97.60 +2.41
AKESO (09926) 42.05 +3.96
---------------------------------------------
(ed)